Commonwealth Equity Services
GMAB icon

Commonwealth Equity Services’s Genmab GMAB Stock Holding History

Commonwealth Equity Services’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$761K Sell
27,691
-818
-3% -$21.7K ﹤0.01% 2943
2026
Q1 		$765K Buy
+28,509
New +$854K ﹤0.01% 2838
2021
Q1 		– Sell
-10,635
Closed -$432K – 3425
2020
Q4 		$432K Buy
10,635
+935
+10% +$35K ﹤0.01% 2255
2020
Q3 		$355K Buy
+9,700
New +$351K ﹤0.01% 2227

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Commonwealth Equity Services's GMAB Position: Q2 2026 in Review

Commonwealth Equity Services reduced its Genmab (GMAB) stake by 2.9% in Q2 2026, selling an estimated $21.7K and leaving 27,691 shares worth $761K. The position accounts for ﹤0.01% of the portfolio, ranked #2943.

Commonwealth Equity Services first reported a position in GMAB in Q3 2020 and has held it in 4 quarters since. The position peaked at $765K in Q1 2026. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Commonwealth Equity Services held 27,691 shares of Genmab worth $761K as of Q2 2026.
  • Commonwealth Equity Services sold 818 Genmab shares in Q2 2026, an estimated $21.7K.
  • Genmab made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #2943 holding.
  • Commonwealth Equity Services first reported a position in Genmab in Q3 2020 and has held it in 4 quarters since.
  • Commonwealth Equity Services's Genmab position peaked at $765K in Q1 2026.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.